Aquaculture industry: A rising star in animal health
The recent acquisition of Elanco’s aquaculture business unit by Merck (MSD) has sent shockwaves through the industry. The transaction’s value alone is noteworthy, but the underlying financial analysis reveals even more intriguing insights.
Aquaculture is still a relatively unknown sector within the veterinary industry, but my recent professional experience in this field has ignited a passion for its potential. With a focus on salmon production in countries like Norway, Chile, Canada, and the United Kingdom, the aquaculture industry is pioneering cutting-edge technologies and attracting investments in novel solutions based on big data and artificial intelligence.
Merck’s strategic vision for animal health emphasizes precision aquaculture farming and innovative product development platforms. The company’s leadership in DNA-based vaccines, acquired as part of the Elanco deal, further cements its commitment to this growing sector.
Driven by passionate individuals, the future of aquaculture is poised to become a leader in technology and innovation for other animal health species.
Brakke: Your partner in unlocking opportunities in the aquaculture animal health market
Our team of experts can help you navigate the complex landscape of the aquaculture industry and identify lucrative growth opportunities. With our deep understanding of the market and extensive network of contacts, we are uniquely positioned to provide you with the insights and support you need to succeed.
Mauri Ronan Moreira
English (United States) 
Portuguese